Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR). (2017)

First Author: Seckl MJ
Attributed to:  MICA: Immunotherapy for oral cancer prevention and treatment funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.2016.69.7391

PubMed Identifier: 28240967

Publication URI: http://europepmc.org/abstract/MED/28240967

Type: Journal Article/Review

Volume: 35

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 14

ISSN: 0732-183X